Inflammation proteins associated with worse clinical outcome to treatment with anti-PD1 in metastatic cutaneous melanoma

被引：0
|
作者：
Svedman, F. Costa [1 ]
Helgadottir, H. [1 ]
Brage, S. Egyhazi [1 ]
机构：
[1] Karolinska Inst, Oncol Pathol Dept, Bioclinicum, Solna, Sweden
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.992
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
866P
引用
收藏
页码：S945 / S945
页数：1
相关论文
共 50 条
  • [1] Anti-PD1 role in treatment of cutaneous melanoma
    Mateus, Christine
    Libenciuc, Cristina
    Robert, Caroline
    [J]. BULLETIN DU CANCER, 2016, 103 (06) : S4 - S11
  • [2] Anti-PD1 and anti-PD-L1 in the treatment of metastatic melanoma
    Simeone, Ester
    Grimaldi, Antonio M.
    Ascierto, Paolo A.
    [J]. MELANOMA MANAGEMENT, 2015, 2 (01) : 41 - 50
  • [3] Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands
    van der Kooij, M. K.
    Joosse, A.
    Speetjens, F. M.
    Hospers, G. A. P.
    Bisschop, C.
    de Groot, J. W. B.
    Koornstra, R.
    Blank, C. U.
    Kapiteijn, E.
    [J]. ACTA ONCOLOGICA, 2017, 56 (01) : 101 - 103
  • [4] Arthritis and Tenosynovitis Associated With the Anti-PD1 Antibody Pembrolizumab in Metastatic Melanoma
    Chan, Matthew M. K.
    Kefford, Richard F.
    Carlino, Matteo
    Clements, Arthur
    Manoliosz, Nicholas
    [J]. JOURNAL OF IMMUNOTHERAPY, 2015, 38 (01) : 37 - 39
  • [5] Predicting the response to anti-PD1 therapy in metastatic melanoma
    Heinzerling, Lucie
    Kirchberger, Michael Constantin
    Walter, Lisa
    Schuler, Gerold
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S576 - S579
  • [6] Intralesional anti-PD1 treatment in patients with metastatic melanoma: The pilot study.
    Samoylenko, Igor
    Korotkova, Olga V.
    Zabotina, Tatiana
    Demidov, Lev V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [7] PERFORMANCE STATUS AS A PREDICTOR OF RESPONSE TO ANTI-PD1 FOR METASTATIC MELANOMA
    Wong, A.
    Williams, M.
    Milne, D.
    Morris, K.
    Lau, P.
    Spruyt, O.
    Fullerton, S.
    McArthur, G.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 71 - 71
  • [8] Metastatic site and response to pembrolizumab (anti-PD1 antibody) in melanoma
    Tumeh, Paul Camille
    Rosenblum, Michael
    Handley, Nathan
    Tsai, Katy
    Rodriguez, Robert S. Rodriguez
    Khurana, Niharika
    Harview, Christina
    Spasic, Marko
    Sanchez, Phillip J.
    Chang, Jeremy
    Shintaku, I. Peter
    Taylor, Emma
    Chmielowski, Bartosz
    Grogan, Tristan
    Elashoff, David A.
    Pierce, Robert H.
    Daud, Adil
    [J]. CANCER RESEARCH, 2015, 75
  • [9] Purple papules during anti-PD1 immunotherapy for metastatic melanoma
    De Luca, Erika V.
    Catapano, Silvia
    Del Regno, Laura
    Di Stefani, Alessandro
    Peris, Ketty
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 (04): : 630 - 632
  • [10] TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma
    Crucitta, Stefania
    Cucchiara, Federico
    Marconcini, Riccardo
    Bulleri, Alessandra
    Manacorda, Simona
    Capuano, Annalisa
    Cioni, Dania
    Nuzzo, Amedeo
    de Jonge, Evert
    Mathjissen, Ron H. J.
    Neri, Emanuele
    van Schaik, Ron H. N.
    Fogli, Stefano
    Danesi, Romano
    Del Re, Marzia
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
12345